Phenylephrine (** Sudafed PE, Neo-Synephrine, Vazculep (injection form) **)
Other Medications
Description
Phenylephrine is not used in the treatment of colorectal cancer (CRC); it is primarily indicated for nasal decongestion and as a pressor agent to treat hypotension. It has no clinical application in CRC therapy.
Mechanism of Action
Phenylephrine is an alpha-adrenergic agonist that primarily acts on ?1 receptors to cause vasoconstriction and increase blood pressure; it does not have direct antineoplastic activity.
Side Effects
Paleness; headache; dizziness; dry mouth; nausea
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT03215797
Phase 3
Archived
Phenylephrine or Norepinephrine for a Better Hemodynamic Stability